Dra. Laura Solán Blanco

RESIDENT PHYSICIAN, GREGORIO MARAÑÓN UNIVERSITY GENERAL HOSPITAL

ASSISTED SPECIALIST PHYSICIAN, HGUGM, FROM 2017 TO DECEMBER 2018

ASSISTED SPECIALIST, JIMÉNEZ DÍAZ FOUNDATION UNIVERSITY HOSPITAL (May 2019 to present)

Attending Physician, Hospitalization Ward.

Head of Hospitalization and Assisted Home Care (HADA)

Member of the board of directors of the Madrid Association of Hematology and Hemotherapy (Since 2024)

1 Proyecto. Mejora de la eficacia de la terapia con células CAR-T para pacientes con Mieloma múltiple. S2022.BMD-7225. (Fundación Jiménez Díaz). 02/01/2023-31/12/2026.

2 Proyecto. INVESTIGADOR PRINCIPAL FJD. Nueva Generación de Inmunoterapias STAb y CAR-¬T Multidianas (Next Generation CART MAD). (Ministerio de Ciencia e Innovación.Investigación). Desde 20/10/2023. 979.200 €.

3 Proyecto. INVESTIGADOR PRINCIPAL FJD. FOVOCIP con título "Un ensayo aleatorizado multicéntrico de fosfomicina frente a ciprofloxacino para la neutropenia febril en pacientes hematológicos: eficacia y seguridad microbiológica".. Teresa Bernal Castillo. (Fundación para la Investigación y la Innovación Biosanitaria del Principado de Asturias (FINBA)). Desde 19/07/2021. Clinical trials NCT05311254, Registered on 5 April 2022

4 Beca. Generación de células CART-CD79B para el tratamiento de pacientes con Linfoma no Hodgkin recaído o refractario Asociación Madrileña de Hematología y Hemoterapia. 15/11/2021-15/11/2023. 12.000 €.

TEACHING ASSOCIATE, AUTONOMOUS UNIVERSITY OF MADRID (UAM)

HEMATOLOGY/ONCOLOGY COORDINATOR, UAX

DOCTORAL THESIS DIRECTOR, DR. JAVIER CORNAGO, From October 2024. Autonomous University of Madrid (UAM).

1 Artículo científico. E. Esquinas; A. Moreno-Sanz; V. Sandá; et al; B. Martín-Antonio. 2024. Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen. Preclinical development of three novel CARs targeting CD79b for the treatment of non-Hodgkin's lymphoma and characterization of the loss of the target antigen. J Immunother Cancer .. 12, pp.1-17. https://doi.org/10.1136/jitc-2024-009485

2 Artículo científico. Juan Carlos Caballero; Nazaret Conejero; Laura Solán; Francisco Javier; Raúl Córdoba; Alberto López. 2024. Unraveling TAFRO Syndrome: An In-Depth Look at the Pathophysiology, Management, and Future Perspectives. Unraveling TAFRO Syndrome: An In-Depth Look at the Pathophysiology, Management, and Future Perspectives. Biomedicines. 12-5. DOI: 10.3390/biomedicines12051076

3 Artículo científico. Alberto Lazaro; Daniel Láinez; Marta González; et al; Juan Manuel Alonso. 2024. Music listening in stem cell transplantation and acute myeloid leukemia: A randomized clinical trial. Music listening in stem cell transplantation and acute myeloid leukemia: A randomized clinical trial. Journal of Pain and Symptom Management. https://doi.org/10.3390/biomedicines12051076.

4 Artículo científico. Gonzalo Castellanos; Laura Pardo; Alberto López; et al; Laura Solán. 2024. Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report. Daratumumab and Nelarabine Treatment as Salvage Therapy for T-Lymphoblastic Lymphoma: A Case Report. Biomedicines. 12-512, pp.1-8. DOI: 10.3390/biomedicines12030512

5 Artículo científico. Ainhoa; Lucia; Paula; et al; Teresa. 2023. FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety. FOVOCIP study: a multicenter randomized trial of fosfomycin versus ciprofloxacin for febrile neutropenia in hematologic patients-efficacy and microbiologic safety. Trials. 24:694. oi: 10.1186/s13063-023-07702-5.

6 Artículo científico. A. López; L. Solán; B. Álvarez; et al; Rm. Rodríguez-Pinilla. 2023. Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin’s Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient. Hemophagocytic Lymphohistiocytosis Secondary to Hodgkin’s Lymphoma with Isolated Bone Marrow Involvement in a Newly Diagnosed HIV Patient. Medicina. 59-7, pp.1-8. DOI: 10.3390/medicina59071274

7 Artículo científico. J.C. Caballero; L. Pardo; M Socorro; et al; A. López. 2023. Primary Effusion Lymphoma, Multicentric Castleman's Disease, and Kaposi's Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report. Primary Effusion Lymphoma, Multicentric Castleman's Disease, and Kaposi's Sarcoma in an HHV-8 and HIV-Positive Patient: A Case Report. Medicina. 59-6. 3. DOI: 10.3390/medicina59061049

8 Artículo científico. R. Bailén; Raquel Alenda; Beatriz Herruzo; et al; Mi Kwon. 2023. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy. Frontiers in Immunology. 14. doi: 10.3389/fimmu.2023.1165759.

9 Artículo científico. Juan Carlos Caballero; Elham Askari; Nerea Carrasco; et al; Laura Solán. 2023. Invasive Cutaneous Candidiasis, Autoimmune Hemolytic Anemia and Pancytopenia: A Challenging Scenario for Waldenström Macroglobulinemia in an Elderly Patient. Invasive Cutaneous Candidiasis, Autoimmune Hemolytic Anemia and Pancytopenia: A Challenging Scenario for Waldenström Macroglobulinemia in an Elderly Patient. Biomedicines. 11-1007. doi: 10.3390/biomedicines11041007.

10 Artículo científico. Edwin Uriel; Alberto López; Laura Solán. 2023. Hyperpigmentation of the Tongue in a Patient With Lymphoma. The Hematologist (ASH). The Hematologist. 20-2, pp.202328. DOI:10.1182/hem.V20.2.202328

11 Artículo científico. Edwin Uriel Suárez; Paula Villalba-Cuesta; Pilar Llamas; Laura Solán. 2022. Seemingly trivial lesion with devastating consequences. Seemingly trivial lesion with devastating consequences. eJHaem. pp.1452-1454. 12 Artículo científico. Miren Vallejo; Paula Muñiz; Mi Kwon; et al; Ismael Buño. 2022. Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms. Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms. Annals of Hematology.

13 Artículo científico. Laura Pardo Gambarte; Aída Franganillo; Javier Cornago Navascués; et al; Laura Solán. 2022. ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report. ZBTB16-RARα-Positive Atypical Promyelocytic Leukemia: A Case Report. Medicina. 58-520. doi: 10.3390/medicina58040520.

14 Artículo científico. Sergio Ramos; Laura Solán; Marta Tomás; et al; Pilar Llamas. 2022. Arterial thrombosis, the unfairly forgotten actor in COVID-19: a case series.Arterial thrombosis, the unfairly forgotten actor in COVID-19: a case series.Biomedical Research. 33-2, pp.53-60.

15 Artículo científico. I. Martínez Alfonzo; D. Lainez-González; L. Solán; et al; Juan M. Alonso-Dominguez. 2022. Flow Cytometry and Molecular Techniques Could Complement Morphological Detection of Leukemic Infiltration in Ascitic Fluids: A Case Report. Flow Cytometry and Molecular Techniques Could Complement Morphological Detection of Leukemic Infiltration in Ascitic Fluids: A Case Report. MDPI. 58-264. DOI: 10.35841/0970-938X.33.1.53-61

16 Artículo científico. R. Bailen; JL Vicario; L. Solán; et al; M Kwon. 2021. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant. 12-674658. doi: 10.3389/fimmu.2021.674658.

17 Artículo científico. L. Solán; D. Carbonell; P. Muñiz; et al; I. Buño. 2021. Elafin as a predictive biomarker of acute skin graft-versus-host disease after haploidentical stem cell transplantation using post-transplant high-dose cyclophosphamide.Elafin as a predictive biomarker of acute skin graft-versus-host disease after haploidentical stem cell transplantation using post-transplant high-dose cyclophosphamide.Frontiers in Immunology. doi: 10.3389/fimmu.2021.516078.

18 Artículo científico. L. Solán; E. Landete; R. Bailén; N. Dorado; G. Oarbeascoa; J. Anguita; JL Díez-Martín; M. Kwon. 2020. Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide. Cytokine release syndrome after allogeneic stem cell transplantation with posttransplant cyclophosphamide. Hematological Oncology. 38, pp.597-603. doi: 10.1002/hon.2772.

19 Artículo científico. M. Kwon; R. Bailén; MJ Pascual-Cascón; et al; JL Díez-Martín. 2019. Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation. Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation. Blood Advances. 3-21, pp.3351-3359. 4 doi: 10.1182/bloodadvances.2019000236.

20 Artículo científico. L. Solán; M. Kwon; D. Carbonell; et al; I. buño. 2019. ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide. ST2 and REG3α as Predictive Biomarkers After Haploidentical Stem Cell Transplantation Using Post-transplantation High-Dose Cyclophosphamide. Frontiers in Immunology. 10-2338, pp.1-12. doi: 10.3389/fimmu.2019.02338.

21 Artículo científico. Mi Kwon; Rebeca Bailñen; Pascual Balsalobre; et al; José L. Dïez-Martín. 2019. Allogeneic stem-cell transplantation in HIV-1-infected patients with high-risk hematological disorders. AIDS. 33-9, pp.1441-1447. doi: 10.1097/QAD.0000000000002209.

22 Artículo científico. Galeano-Valle F.; Solán-Blanco L; Alvarez-Sala-Walter L. 2018. Extramedullary ureteral plasmocytoma causing postrenal acute renal failure. Medicina Clinica. ELSEVIER. 151-5, pp.211-212. doi: 10.1016/j.medcli.2018.03.003.

23 Artículo científico. González-López TJ; Pascual C; Álvarez-Román MT; et al; Gonzalez-Porras JR. 2015. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia.American Journal of Hematology. 90-3, pp.40-43. doi: 10.1002/ajh.23900.

24 Artículo de divulgación. Sergio Ramos; Daniel Láinez; Laura Solán; et al; Juan Manuel Alonso. 2024. When the devil is in the details: similarities and differences between WHO and ICC classifications of AML. When the devil is in the details: similarities and differences between WHO and ICC classifications of AML. Leukemia Research. 107440. doi: 10.1016/j.leukres.2024.107440.

25 Capítulo de libro. 2021. Novel Immunological Biomarkers for Allogeneic HSCT Outcome.Elafin as a predictive biomarker of acute skin graft-versus-host disease after haploidentical stem cell transplantation using post-transplant high-dose cyclophosphamide. Lausanne: Frontiers Media SA.

26 Capítulo de libro. 2021. Novel Immunological Biomarkers for Allogeneic HSCT Outcome. ST2 and REG3α as predictive biomarkers after haploidentical stem cell transplantation using high-dose post-transplantation cyclophosphamide.Lausanne: Frontiers Media SA.

AMHH Research Grant 2020/2021: "Generation of CD79B CAR-T cells for the treatment of patients with R/R NHL"

Quirón Salud Award for the best patient experience initiative 2022 (HADA)

7th Awards for the Best Initiatives in Health, Patient Experience, and Efficiency 2023 (HADA)

Best Poster Award at the Quirónsalud Clinical and Care Excellence Conference 2024

Quirónsalud Healthcare Innovation Award 2024 (Home Transfusion)